Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 



DoD Prostate Cancer Research Program Opportunities

Physician Research Award: This Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. Pre-Application Deadline: August 16, 2018
Early Investigator Research Award : This Award supports prostate cancer-focused research opportunities for individuals in the early stages of their careers, under the guidance of one or more designated Mentors. Pre-Application Deadline: August 16, 2018




Availability of Administrative Supplements for NCI Grant and Cooperative Agreement Awards to Support Pediatric Cancer Control Research Across the Lifespan

This Notice informs current NCI awardees that NCI is interested in Administrative Supplement applications that seek to enhance pediatric cancer control research across the lifespan.

Application Deadline: August 17, 2018

Notice of Availability of Administrative Supplements for Integrative Data Analysis to Extend Research in Cancer Control and Population Sciences

This Notice informs current NCI awardees that NCI is interested in Administrative Supplement applications that seek to integrate/merge or link two or more independent datasets to answer novel cancer prevention and control questions.

Application Deadline: August 17, 2018



Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (R01/R21)

The purpose of the FOA is to advance our understanding of the modes of transmission of Kaposi sarcoma-associated herpesvirus; the biology of the initial steps of infection; and risk factors for infection in populations living with HIV or at high risk of developing HIV.

Application Deadline: August 18, 2018



NIH Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions-D43

The purpose of this FOA is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.

Deadline for Application: August 23, 2018

L earn more about Fogarty HIV>>


DoD Kidney Cancer Research Program Funding Opportunities for 2018

• Idea Development Award – To support new ideas that represent innovative, high-risk/high-gain approaches to kidney cancer research, and have the potential to make an important contribution to kidney cancer. Letter of Intent Due: September 5, 2018
• Physicians Research Award – To support a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in kidney cancer research. Letter of Intent Due: September 5, 2018
• Technology Development Award- To support emerging technologies to aid clinical and patient outcomes. Letter of Intent Due: September 5, 2018
• Translational Research Partnership – To support partnerships between clinicians and laboratory scientists that accelerate ideas in kidney cancer into clinical applications. Letter of Intent Due: September 5, 2018


Obesity Policy and Program Evaluation

This FOA establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors and/or weight outcomes in an effort to prevent or reduce obesity.

Application Deadlines :

August 23, 2018; September 13, 2018; October 10, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-854.html


Cooperative Human Tissue Network

The purpose of this FOA, issued by the NCI, is to support the Cooperative Human Tissue Network (CHTN). The goal for CHTN is to collect and distribute to investigators high quality human tissue specimens to facilitate basic and early translational cancer research.

Application Deadline: August 28, 2018


NCI Community Oncology Research Program (NCORP) Research Bases

This FOA solicits applications from institutions/organizations to participate as "Research Bases" for the NCI-supported Community Oncology Research Program (NCORP).

Application Deadline: August 31, 2018



NCI Community Oncology Research Program (NCORP) Community Sites

This FOA solicits applications from institutions/organizations to participate as "Community Sites" for the NCI-supported Community Oncology Research Program (NCORP).

Application Deadline: August 31, 2018



NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites

This FOA solicits applications from institutions/organizations to participate as "Minority/Underserved Community Sites" for the NCI-supported Community Oncology Research Program (NCORP).

Application Deadline: August 31, 2018



Elsa U. Pardee Foundation Grant

The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. 

Application Deadline: August 31, 2018



Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 and R43/R44)

This FOA encourages both (R43/R44) Small Business Innovation Research and (R41/R42) Small Business Technology Transfer grant applications from small business concerns to develop or adapt, apply, and validate existing or emerging technologies into user-friendly products for cancer prevention, diagnosis, or treatment in low-resource settings. 

Application Deadline: September 5, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-801.html


Gilead Sciences Research Scholars Program in Hematology/Oncology

Grants of up to $130,000 over two years will be awarded to junior faculty researchers for innovative translational research projects in hematology/oncology (with a focus on hematologic malignancies) that can be either based around a clinical trial with strong correlative science or laboratory investigation.

Application Deadline: September 7, 2018
 


"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01/R21)

The purpose of this FOA is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or AIDS. 

Application Deadline: September 7, 2018



HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01/R21)

The purpose of this FOA is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges impacting HBV and HIV co-infected hosts and (b) advance the discovery and development of novel HBV interventions that are safe and achieve a functional cure in HIV and HBV co-infected individuals.     

Application Deadline: September 7, 2018



In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01/R21)

The purpose of this FOA is to stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection and create a better understanding of the immunopathogenic interactions between HBV and HIV.   

Application Deadline: September 7, 2018



Harnessing Big Data to Halt HIV (R01)

The purpose of this FOA is to promote research that transforms understanding of HIV transmission, the HIV care continuum, and HIV comorbidities using Big Data Science.

Application Deadline: September 7, 2018



Administrative Supplements to Support Cancer Disparity Collaborative Research

The purpose of this trans-NCI FOA is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers.

Application Deadline: September 10, 2018

DoD Breast Cancer Research Program Funding Opportunities

Applications to the FY18 BCRP are being solicited for the DHA. The BCRP supports innovative, high-impact research focused on ending breast cancer. 

• Breakthrough Award Level 3 & 4: Supports promising research that has the potential to lead to or make breakthroughs in breast cancer. Preproposal Due: September 14, 2018
• Breakthrough Award Level 1 & 2: Supports promising research that has the potential to lead to or make breakthroughs in breast cancer. LOI Due: November 1, 2018



Prostate Cancer Research Program Funding Opportunities 

The mission of the PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all men experiencing the impact of the disease.

    Health Disparity Research Award – Letter of Intent Due: September 20, 2018
    Health Disparity Scholar Award – Letter of Intent Due: September 20, 2018

http://cdmrp.army.mil/funding/pcrp


Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)

The over-arching goal of this NCI R25 program is to support educational activities that enhance the diversity of the nation's biomedical, behavioral, and clinical research workforce.

Application Deadline: September 25, 2018



Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)

The over-arching goal of this NCI R25 program is to support educational activities that enhance the diversity of the nation's biomedical, behavioral, and clinical research workforce.

Application Deadline: September 25, 2018



Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)

This FOA encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes.

Application Deadline: October 5, 2018


Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional)

The purpose of this FOA is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN).  The RDCRCs are intended to advance the diagnosis, management, and treatment of rare diseases with a focus on clinical trial readiness.  

Application Deadline: October 9, 2018

 

Administrative Supplements for Research on Dietary Supplements

This FOA announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. 

Application Deadline: October 15, 2018

 

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents

This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods.

Application Deadline: October 15, 2018



Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01/R21)

The purpose of this FOA is to support basic research examining how Electronic Nicotine Delivery Systems (ENDS) aerosols affect normal and disease states relevant to human cells, tissues and organs.

Application Deadline: October 24, 2018


Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01/R21)

The purpose of this FOA is to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations.

Application Deadline: October 24, 2018



Tobacco Use and HIV in Low and Middle Income Countries (R01)

The purpose of this FOA is to encourage research focused on tobacco use and HIV infection in low and middle income countries.

Application Deadline: November 1, 2018


Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 5, 2018



The Role of Epitranscriptomics in Development and Disease 

The purpose of this FOA is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. 

Application Deadline: November 7, 2018

 

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 16, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html



Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine

The purpose of this FOA is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials.

Application Deadline: November 19, 2018

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants.  


Luminary Award of Excellence

The YNHH Smilow Luminary Award of Excellence will serve to recognize, and ceremoniously acknowledge, those individuals and/or teams who consistently exceed performance expectations and deliver high quality cancer care for our patients, families and the health system through community service, optimization/ innovative solutions, patient experience, leadership and research initiatives. Nominations should be submitted directly to Luminary@ynhh.org